Inspiration meets innovation at Brandweek, the ultimate marketing experience. Join industry luminaries, rising talent and strategic experts in Phoenix, Arizona this September 23–26 to assess challenges, develop solutions and create new pathways for growth. Register early to save.
Pfizer last week selected winners in reviews for the creative accounts of three drugs formerly handled by IPG’s Deutsch. IPG’s McCann-Erickson beat out Havas’ Arnold, WPP’s Berlin Cameron/Red Cell, Publicis and Omnicom’s TBWA\Chiat\ Day for Bextra. For Zoloft, Publicis’ Kaplan Thaler Group overcame Arnold, Publicis and Omnicom’s Merkley Newman Harty & Partners. Berlin Cameron bested Kaplan Thaler, Merkley and TBWA\C\D for Zyrtec. Billings for each account are estimated at $50 million-plus. Separately, Pfizer named Arnold and Kaplan Thaler finalists for duties on the $80 million Celebrex account; WPP’s J.
WORK SMARTER - LEARN, GROW AND BE INSPIRED.
Subscribe today!
To Read the Full Story Become an Adweek+ Subscriber
Already a member? Sign in